Target
RAC-alpha serine/threonine-protein kinase [1-123]
Ligand
BDBM50338948
Substrate
n/a
Meas. Tech.
SPR Competitive Binding Assay
Ki
8400±n/a nM
Citation
 Mahadevan, DMeuillet, EJMash, Jr., EAGokhale, VMPowis, GZhang, S Small molecule inhibitors of the pleckstrin homology domain and methods for using same US Patent  US9320734 Publication Date 4/26/2016 
Target
Name:
RAC-alpha serine/threonine-protein kinase [1-123]
Synonyms:
AKT1 | AKT1_HUMAN | PKB | RAC | RAC-alpha serine/threonine-protein kinase (Akt)
Type:
Enzyme
Mol. Mass.:
14664.42
Organism:
Homo sapiens (Human)
Description:
PLECKSTRIN HOMOLOGY DOMAIN RESIDUES 1-123 (PH Domain)
Residue:
123
Sequence:
MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSG
  
Inhibitor
Name:
BDBM50338948
Synonyms:
4-Octyl-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide | CHEMBL1685048 | US9320734, 153
Type:
Small organic molecule
Emp. Form.:
C16H23N3O2S2
Mol. Mass.:
353.503
SMILES:
CCCCCCCCc1ccc(cc1)S(=O)(=O)Nc1nncs1
Structure:
Search PDB for entries with ligand similarity: